Literature DB >> 3607295

Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.

F Rodeghiero, G C Castaman, E Di Bona, M Ruggeri, E Dini.   

Abstract

A syndrome of marked fetal wastage is associated with congenital factor XIII deficiency in adult women. A previously unreported case of a woman with factor XIII deficiency is described, in which substitutive treatment with normal plasma or placental factor XIII concentrate permitted two normal pregnancies. Factor XIII activity was maintained above 1-2% with intermittent infusion of 300 ml to 450 ml of plasma every 14 days or of 500 units of concentrate every 21 days. This case confirms the only other case so far reported in which factor XIII substitutive therapy was able to permit a normal pregnancy in a woman with factor XIII deficiency and seems to suggest factor XIII to be involved in the process of annidation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607295     DOI: 10.1007/bf00319641

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  11 in total

1.  Type I and type II disease in congenital factor XIII deficiency. A further demonstration of the correctness of the classification.

Authors:  A Girolami; M G Cappellato; A R Lazzaro; M Boscaro
Journal:  Blut       Date:  1986-11

Review 2.  The fibrin stabilizing factor, factor XIII.

Authors:  F Duckert
Journal:  Blut       Date:  1973-03

3.  Documentation of the plasma factor XIII deficiency in man.

Authors:  F Duckert
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

4.  Subunit A of factor XIII regulates subunit B plasma concentration.

Authors:  F Rodeghiero; M Morbin; T Barbui
Journal:  Thromb Haemost       Date:  1981-10       Impact factor: 5.249

5.  Genetic heterogeneity of factor XIII deficiency: first description of unstable A subunits.

Authors:  S Castle; P G Board; R A Anderson
Journal:  Br J Haematol       Date:  1981-06       Impact factor: 6.998

6.  Human factor XIII: fibrin-stabilizing factor.

Authors:  L Lorand; M S Losowsky; K J Miloszewski
Journal:  Prog Hemost Thromb       Date:  1980

7.  Factor 13 deficiency with severe hemorrhagic diathesis.

Authors:  S Fisher; M Rikover; S Naor
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

8.  Fibrin cross-linking in congenital factor XIII deficiency.

Authors:  F Rodeghiero; T Barbui
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

9.  Hereditary factor XIII deficiency: report of four families and definition of the carrier state.

Authors:  S Berliner; A Lusky; A Zivelin; M Modan; U Seligsohn
Journal:  Br J Haematol       Date:  1984-03       Impact factor: 6.998

10.  Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.

Authors:  L Lorand; T Urayama; J W De Kiewiet; H L Nossel
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  3 in total

1.  Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus.

Authors:  R Adány; L Muszbek
Journal:  Histochemistry       Date:  1989

Review 2.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

3.  Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.

Authors:  Nizar Abdel-Samad
Journal:  Am J Case Rep       Date:  2017-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.